Skip to content
10-K

Annual Report

Bluejay Diagnostics, Inc. BJDX

0001213900-26-024616

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 972.22K sh
Shares Diluted FY 2025 · Dec 31, 2025 449.04K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 45.85K sh
Capex FY 2025 · Dec 31, 2025 $173.74K
Capex FY 2025 · Dec 31, 2024 $306.78K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.05M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$7.82M
Cash And Equivalents FY 2025 · Dec 31, 2025 $5.16M
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.3M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.98M
Stockholders Equity FY 2025 · Dec 31, 2024 $5.73M
Stockholders Equity FY 2025 · Dec 31, 2023 $2.89M
Current Liabilities FY 2025 · Dec 31, 2025 $1.12M
Current Liabilities FY 2025 · Dec 31, 2024 $810.37K
Total Liabilities FY 2025 · Dec 31, 2025 $1.14M
Total Liabilities FY 2025 · Dec 31, 2024 $927.92K
Current Assets FY 2025 · Dec 31, 2025 $5.46M
Current Assets FY 2025 · Dec 31, 2024 $4.9M
Total Assets FY 2025 · Dec 31, 2025 $7.12M
Total Assets FY 2025 · Dec 31, 2024 $6.66M
Eps Diluted FY 2025 · Dec 31, 2025 −$15.25
Eps Diluted restated FY 2025 · Dec 31, 2024 −$456.75
Eps Basic FY 2025 · Dec 31, 2025 −$15.25
Eps Basic restated FY 2025 · Dec 31, 2024 −$456.75
Rd Expense FY 2025 · Dec 31, 2025 $3.05M
Rd Expense FY 2025 · Dec 31, 2024 $3.47M
Net Income FY 2025 · Dec 31, 2025 −$6.85M
Net Income FY 2025 · Dec 31, 2024 −$7.72M
Operating Income FY 2025 · Dec 31, 2025 −$6.95M
Operating Income FY 2025 · Dec 31, 2024 −$7.17M